Cited by 375Ubiquitin and proteasome pathwaysAutophagy in Disease and TherapyParkinson's Disease Mechanisms and Treatments

USP8 regulates mitophagy by removing K6‐linked ubiquitin conjugates from parkin

Open access
Durcan, Thomas M, Tang, Matthew Y, Pérusse, Joëlle R, Dashti, Eman A, Aguileta, Miguel A, McLelland, Gian‐Luca, Gros, Priti, Shaler, Thomas A +3 more·2014·The EMBO Journal

Abstract

Mutations in the Park2 gene, encoding the E3 ubiquitin-ligase parkin, are responsible for a familial form of Parkinson's disease (PD). Parkin-mediated ubiquitination is critical for the efficient elimination of depolarized dysfunctional mitochondria by autophagy (mitophagy). As damaged mitochondria are a major source of toxic reactive oxygen species within the cell, this pathway is believed to be highly relevant to the pathogenesis of PD. Little is known about how parkin-mediated ubiquitination is regulated during mitophagy or about the nature of the ubiquitin conjugates involved. We report here that USP8/UBPY, a deubiquitinating enzyme not previously implicated in mitochondrial quality control, is critical for parkin-mediated mitophagy. USP8 preferentially removes non-canonical K6-linked ubiquitin chains from parkin, a process required for the efficient recruitment of parkin to depolarized mitochondria and for their subsequent elimination by mitophagy. This work uncovers a novel role for USP8-mediated deubiquitination of K6-linked ubiquitin conjugates from parkin in mitochondrial quality control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.201489729

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Abnormal parkin ubiquitination prevents its proteasomal degradation and impedes parkin-mediated mitophagy.

    “abnormal parkin ubiquitination was shown to prevent its proteasomal degradation and impede parkin-mediated mitophagy44.”

    From Altered mitochondrial dynamics and function in APOE4-expressing astrocytes (2020) · cites this paper as [44]

    The paper reports that increased K6-linked ubiquitin conjugates on parkin delay parkin-mediated mitophagy (figure legend, “Viral-mediated infection and lysis of cortical neurons”; page unavailable). It also reports that reduced USP8 activity appears to protect parkin from degradation, but says K6-linked ubiquitination is *likely* to protect it from degradation in the proteasome **or lysosome** (“USP8 selectively removes K6-linked ubiquitin conjugates from parkin” and discussion; pages unavailable). The claim overstates this as demonstrated prevention of proteasomal degradation specifically. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Durcan, T. M., Tang, M. Y., Pérusse, J. R., Dashti, E. A., Aguileta, M. A., McLelland, G., Gros, P., Shaler, T. A., Faubert, D., Coulombe, B., & Fon, E. A.
Affiliations
  • Montreal Neurological Institute and Hospital (CA)
  • Montreal Clinical Research Institute (CA)
  • SRI International (US)
Corresponding author
Fon, Edward A
Venue
The EMBO Journal
Published
2014-09-12
Volume
33
Issue
21
Pages
2473-2491
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2113190139
Cited by
375
References
10
Citations by year
2026: 25 · 2025: 22 · 2024: 35 · 2023: 36 · 2022: 33 · 2021: 37 · 2020: 42 · 2019: 31 · 2018: 24 · 2017: 33 · 2016: 26 · 2015: 27 · 2014: 3
FWCI
11.20
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Parkinson's Society of Canada
  • CIHR Operating grant (MOP‐62714)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
USP8, Parkin, mitophagy, deubiquitination, mitochondrial quality control, Parkinson's disease, E3 ubiquitin ligase, mitochondrial depolarization, autophagy
MeSH terms
HeLa Cells, Humans, Mitochondria, Endopeptidases, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases, Ubiquitination, Endosomal Sorting Complexes Required for Transport, HEK293 Cells, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review